UMB Bank’s Charles River Laboratories CRL Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $104K | Buy |
688
+512
| +291% | +$77.7K | ﹤0.01% | 811 |
|
|
2025
Q1 | $26.5K | Sell |
176
-93
| -35% | -$14K | ﹤0.01% | 1257 |
|
|
2024
Q4 | $49.7K | Sell |
269
-104
| -28% | -$19.2K | ﹤0.01% | 918 |
|
|
2024
Q3 | $73.5K | Sell |
373
-1
| -0.3% | -$197 | ﹤0.01% | 768 |
|
|
2024
Q2 | $77.3K | Sell |
374
-26
| -7% | -$5.37K | ﹤0.01% | 744 |
|
|
2024
Q1 | $108K | Buy |
400
+2
| +0.5% | +$542 | ﹤0.01% | 681 |
|
|
2023
Q4 | $94.1K | Sell |
398
-172
| -30% | -$40.7K | ﹤0.01% | 711 |
|
|
2023
Q3 | $112K | Hold |
570
| – | – | ﹤0.01% | 674 |
|
|
2023
Q2 | $120K | Sell |
570
-50
| -8% | -$10.5K | ﹤0.01% | 669 |
|
|
2023
Q1 | $125K | Sell |
620
-2
| -0.3% | -$404 | ﹤0.01% | 653 |
|
|
2022
Q4 | $135K | Buy |
622
+2
| +0.3% | +$434 | ﹤0.01% | 647 |
|
|
2022
Q3 | $122K | Buy |
620
+267
| +76% | +$52.5K | ﹤0.01% | 684 |
|
|
2022
Q2 | $76K | Buy |
353
+34
| +11% | +$7.32K | ﹤0.01% | 805 |
|
|
2022
Q1 | $91K | Hold |
319
| – | – | ﹤0.01% | 796 |
|
|
2021
Q4 | $121K | Buy |
+319
| New | +$121K | ﹤0.01% | 771 |
|